OpenAI and Molecule.one have demonstrated a near-autonomous AI chemist, powered by GPT-5.4, that significantly improved a complex reaction crucial in medicinal chemistry. This development showcases AI’s potential to accelerate drug discovery and pharmaceutical research.
Source: OpenAI